Unbelievable that because of the sp being impacted by market machinations due to the Dendreon factor and the global situation you impugn the standard of management and disclosure.
You are entitled to your opinions but so are all the investors who understand the market conditions and have the view that the company is working well towards its goals. What would you expect the company to tell you that it hasnt disclosed that would result in a better share price? In my case one things for certain if I held your negative view of company management I would not be in the stock. Good management is critical in the high risk area of biotechs.
We have erratic markets and global economic uncertainty and PRR has ticked every box including the funding to complete its trials. Huge ticks from me in that regard for a job well done. The company cant be held responsible for the current market conditions and the flow on effect of the dendreon factor.
In closing if you feel that anyone who posts positively on the stock is a ramper then given the pure speculation in your post about Nasdaq and the CEO then imo your post constitutes an inappropriate downramp.
PRR Price at posting:
15.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)